http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020008498-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C243-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N39-04
filingDate 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be5d639b19c528da915e2c17b15d157f
publicationDate 2020-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020008498-A
titleOfInvention DERIVATIVES OF SOBETIROME.
abstract Compounds that function as thyromimetics are provided, wherein said compounds have utility in the treatment of diseases such as neurodegenerative disorders. Pharmaceutical compositions containing such compounds, as well as methods for their use and preparation, are also provided. Said compounds have the structure of Formula (I) as shown herein, or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope or salt thereof.
priorityDate 2018-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9862248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478196

Total number of triples: 34.